NuScale Power Corporation (NYSE: SMR) (NuScale), the industry-leading provider of proprietary and innovative advanced small modular reactor (SMR) nuclear technology, and Ebara Elliott Energy (EEE), a ...
Leading bereavement notification specialist NotifyNOW, a service of Phillips & Cohen Associates (PCA), has unveiled a new partnership with Capital One UK to help ease the stress and emotional toll of ...
Caleres (NYSE: CAL), a market-leading portfolio of consumer-driven footwear brands, today reported financial results for the fourth quarter and full year 2025, as well as guidance for first quarter ...
Maui Rapid Response launched the Kahua Card program last year as a six-month pilot to see if cash could boost those still struggling to recover from the August 2023 tragedy that killed at least 102 ...
Accenture (NYSE: ACN) reported financial results for the second quarter of fiscal 2026 ended February 28, 2026. This press release features multimedia. View the full release here: All comparisons are ...
Empire Petroleum Corporation (NYSE American: EP) ("Empire" or the "Company"), an oil and gas company with current producing assets in New Mexico, North Dakota, Montana, Texas, and Louisiana, announced ...
Global oil and natural gas prices have soared after Iran attacked a key natural gas facility in Qatar that can supply one-fifth of the world's gas, and two oil refineries in Kuwait ...
Iran hit a Saudi refinery on the Red Sea and set Qatari liquefied natural gas facilities and two Kuwaiti oil refineries ablaze, sending international oil and gas prices soaring Thursday ...
Modiv Industrial To Report Fourth Quarter and Full Year 2025 Financial Results on March 25, 2026 & Declares Quarterly Dividends for Preferred Shareholders and Monthly Distribution ...
Bristol Myers Squibb (NYSE: BMY) will announce results for the first quarter of 2026 on Thursday, April 30, 2026. Company executives will review financial results with the investment community during ...
Fervo Energy , the global pioneer of next-generation geothermal deployment, today announced the successful close of $421 million in non-recourse debt financing for the first phase of its flagship Cape ...
(NYSE: PFE) today announced positive topline results from the Phase 3 TALAPRO-3 study of TALZENNA ® (talazoparib), an oral poly ADP-ribose polymerase (PARP) inhibitor, in combination with XTANDI ® ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results